Simple item record
Title: A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR - implications for therapeutic failure and drug resistance
Authors: Paris, DH; Jenjaroen, K; Blacksell, SD; Phetsouvanh, R; Wuthiekanun, V; Newton, PN; Day, NPJ; Turner, GDH
Keywords: KENYAN RETAIL SECTOR; SOUTHEAST-ASIA; COMBINATION THERAPY; ANTIMALARIAL-DRUGS; FAKE ARTESUNATE; ARTEMISININ; MALARIA; COUNTERFEIT; CAMBODIA; PYRIMETHAMINE
Issue Date: 2009
Publisher: MALARIA J
Citation: Malar. J.;28-Jul;2009;8;
Abstract: Background: Counterfeit oral artesunate has been a major public health problem in mainland SE Asia, impeding malaria control. A countrywide stratified random survey was performed to determine the availability and quality of oral artesunate in pharmacies and outlets (shops selling medicines) in the Lao PDR (Laos). Methods: In 2003, 'mystery' shoppers were asked to buy artesunate tablets from 180 outlets in 12 of the 18 Lao provinces. Outlets were selected using stratified random sampling by investigators not involved in sampling. Samples were analysed for packaging characteristics, by the Fast Red Dye test, high-performance liquid chromatography (HPLC), mass spectrometry (MS), X-ray diffractometry and pollen analysis. Results: Of 180 outlets sampled, 25 (13.9%) sold oral artesunate. Outlets selling artesunate were more commonly found in the more malarious southern Laos. Of the 25 outlets, 22 (88%; 95% CI 68-97%) sold counterfeit artesunate, as defined by packaging and chemistry. No artesunate was detected in the counterfeits by any of the chemical analysis techniques and analysis of the packaging demonstrated seven different counterfeit types. There was complete agreement between the Fast Red dye test, HPLC and MS analysis. A wide variety of wrong active ingredients were found by MS. Of great concern, 4/27 (14.8%) fakes contained detectable amounts of artemisinin (0.26-115.7 mg/tablet). Conclusion: This random survey confirms results from previous convenience surveys that counterfeit artesunate is a severe public health problem. The presence of artemisinin in counterfeits may encourage malaria resistance to artemisinin derivatives. With increasing accessibility of artemisinin-derivative combination therapy (ACT) in Laos, the removal of artesunate monotherapy from pharmacies may be an effective intervention.
URI: http://hdl.handle.net/11267/2415
ISSN: 1475-2875

There are no files associated with this item.

View Statistics